Don't miss more helpful resources about Boston Scientific’s Drug-Eluting Technologies in the Resources Center and join the Drug Eluting Technology Community to receive the latest news of Drug Eluting Technologies.
The Eluvia Stent is uniquely designed to deliver paclitaxel when restenosis is most likely to occur. Watch a video to learn how it works:

Discover how the Eluvia Stent was designed and engineered to solve the unique challenge of restenosis in the SFA. The only SFA stent to utilize polymer-based technology with proven biocompatibility—Eluvia sustains drug release beyond 12 months to match restenosis.

September 9, 2016

About Drug-Eluting Technologies
Clinical Program
Resources Center
News & Events

WANT TO KNOW MORE?

Join our Drug-Eluting Technologies Community

Sign Up for Product Updates

Receive the latest news of Drug Eluting Technologies

SIGN UP